Research programme: herpes simplex virus vaccine - MymeticsAlternative Names: Virosome-based HSV vaccine - Mymetics
Latest Information Update: 13 Mar 2014
At a glance
- Originator Mymetics Corporation
- Class Vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Herpes simplex virus infections
Most Recent Events
- 10 Mar 2014 Preclinical trials in Herpes simplex virus infections (prevention) in Netherlands (unspecified route)
- 27 Jul 2012 Early research in Herpes simplex virus infections in Netherlands (unspecified route)